Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
+100%
big hits!!!! news out?
anyone in contact with CEO? email or telephone?
yes, you can see it, there is no dilution
epic run should start with break of ,013
load as much as you can, shorts trying to hold it down
+200% need 1000%
$GCEH huuuuuuuuuuuuuuuuuuuuuge neeeeeeeeeeeeeeewwwwwwwwwwsssssss
$GCEH ExxonMobil-Global-Clean-Energy-Holdings-Sign-Agreement
load if you can...incredible big news
booooooooooooooooooom
GAHC reserve split cancelled!!!
http://archive.fast-edgar.com//20190314/A3A2222CK222J2Z2222C22ZZ3S6KL28222B2/
GAHC reserve split cancelled!!!
http://archive.fast-edgar.com//20190314/A3A2222CK222J2Z2222C22ZZ3S6KL28222B2/
GAHC reserve split cancelled
adding LFAP today
sold 100k pm
Astro Aerospace Partners with Paterson Composites to Build Its Autonomous Passenger Drone
https://finance.yahoo.com/news/astro-aerospace-partners-paterson-composites-103000505.html
Astro Aerospace Acquires VTOL Industry Leader Passenger Drone
Astro Aerospace continues its journey building the future of flying by becoming the first company to go public with its fully-functional prototype in the Passenger Drone market and welcomes leading drone expert, Paul Beard, as its newest director and advisor
LEWISVILLE, TX / ACCESSWIRE / May 8, 2018 / Astro Aerospace (www.flyastro.com) (ASDN), has acquired the assets to VTOL industry leader, Passenger Drone (www.passengerdrone.com). Porsche Consulting states that vertical mobility offers mankind a serious shot at turning the dream of flying into a reality for everyone, and inspection, goods, and passenger services have the potential to become a global market worth $74 billion.
Astro Aerospace's Passenger Drone is a state-of-the-art aerial transport vehicle that is slated to improve urban mobility and enable passengers to arrive at their destination quickly and swiftly. Designed from the ground up for maximum reliability, displaying 360° surround view optimizing the travel experience with wide cabin glass that encase the cockpit for optimal seating comfort.
Along with this acquisition, Astro is pleased to announce the addition of leading drone expert, Paul Beard, CEO of Uavionix (www.uavionix.com), to its board.
"I look forward to working with Astro Aerospace as a board member and advisor, bringing over 30 years of expertise to a seasoned team," says Paul Beard, CEO of Uavionix. "Working alongside Astro's development team, we will elevate the company to a new level that will offer investors and buyers a safe, durable, autonomous, and exciting piece of technology that leads us into the future."
Constructed from carbon fiber, the Drone creates a sleek design and offers structural efficiency. It's fibre-optic technology reduces aircraft weight magnetic interference. Astro's functioning prototype includes its VTOL capabilities and hosts 16 individual rotors to maximize safety performance, and is eco-friendly and emission-free. Touch flight control enables passengers to fly the Drone manually or autonomously.
"We're excited to take Astro's technology to the next level as a public company, giving the opportunity to everyone who has dreamed of flying the ability to experience the thrill in a safe and controlled environment with the Astro Passenger Drone," says CEO of Astro, Bruce Bent.
Astro Aerospace will trade under trade the ticker ASDN in the United States.
About:
Astro Aerospace is the developer of the world's most advanced autonomous, unmanned, and manned flying vehicles. Our mission is to make self flying unmanned and manned vehicles available to anyone, at anytime, from anywhere, and turn this new and exciting aircraft into mainstream way of transportation. Visit www.flyastro.com for more information.
For investor inquiries contact Mike@flyastro.com
SOURCE: Astro Aerospace Ltd.
Name change. Merger?
sounds great
ANDI last chance to get in under .02 next minutes!!!!
huge news out
OTTV last chance to grap some cheap shares, will fly over HOD
thank you so much for these sub .005s , they will be golden next week
,0052 is +70% from last friday. Any reason to sell in panic .... no lol
OTTV twitter follower eploding
pm hit, unusual
Chart looks ready, loading today, running tomorrow
.0007s are falling
.0005s going to fall
i smell news coming
bid is upticking
.0003s gone ...will fly over .0004
Come on guys, will fly over .0013 adding here
.0004 is up again and ask so thin.. think will run again soon
huge bid in here
Rising Biosciences, Inc. Launches Corporate Website, Announces Executive Research Team
[Marketwired]
MarketwiredApril 27, 2017
NEW YORK, NY--(Marketwired - Apr 27, 2017) - Rising India Inc. ( OTC : RSII ) is pleased to announce that Rising Biosciences, Inc., The Company's recently finalized merger entity, has officially launched its corporate website, www.Risingbiosciences.com detailing its mission statement, corporate objectives and newly appointed research executives.
Rising Biosciences, Inc. is a research & development company focusing on oral and topical cannabis and non-cannabis based pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry. Operations will be helmed by a team of chemists, physicians, pharmacists and medical marijuana industry veterans for the development of products in a clinical lab environment with a focus on creating product that can be metabolized by the body more efficiently, and with delivery methods more acceptable than smoking, tinctures and oils available on the market today.
In addition to C-Level execs including previously announced execs CEO Robert Weber and Jim DiPrima, who will serve as CFO, the Rising Biosciences has also secured Arthur Hall as Chief Operating Officer. Hall, a seasoned executive in the medical marijuana industry, has extensive experience in laboratory environments in the states of Washington and Oregon, as well as a hands-on background in processing and production, particularly in development of new safe extraction methods, which have become industry standards today.
Rising Biosciences has assembled an impressive team of executives including its Chief Medical Officer, Gary C. Bernard, M.D. who also serves as President & CEO of Pointe Medical Services, Inc., Pointe Med Pharmacy and Live Well MD.
Douglas Bowes will serve as Director of Brand Development for Rising Biosciences. Bowes is a successful entrepreneur with over 35 years and the principal owner of a state of the art sterile and non-sterile compounding pharmacy.
Richard Vallette will serve as Director of Pharmacology for the company. He is a certified Pharmacy Regulatory Specialist with certifications in Specialty Pharmaceutical Compounding Techniques and He currently owns and operates a consulting business that provides regulatory and compliance strategies outlining the proper handling of pharmaceuticals to professionals in various medical fields.
CEO Weber is thrilled with the recent appointments, "We are pleased to have assembled our core team of execs and researchers and anticipate explosive growth in the sector given the current industry climate and prospects therein. The business is now prepared to move forward with products we have been working on the first being a non-opioid topical pain cream and the second being a peptide based serum for post melanoma scar reduction although not cannabis based products they will be marketable worldwide."
We also are pleased to announce the Ohio location has begun renovation and we anticipate completion this quarter.
$RSII on Twitter for LIVE company updates! www.twitter.com/risingindiausa
Forward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward- looking statements to reflect events or circumstances after the date of this release.